At the news
? NEUTRALIMPACT 2/10 SC 13G/A filed Nov 5, 2026 at 13:14 ET
FMR LLC (Fidelity) filed an amended Schedule 13G for Charles River Laboratories, reporting beneficial ownership of 5,922,755 shares (12.4% of common stock) as of September 30, 2026. This is a routine passive stake update filed one day after the company's Q3 2026 earnings beat, and the stake appears unchanged from the prior filing as of August 31, 2026.
- FMR LLC reported beneficial ownership of 5,922,755 shares of CRL common stock as of September 30, 2026.
- The stake represents 12.4% of outstanding shares.
- This is an amendment to a Schedule 13G, indicating passive investment intent.
- The filing was made on November 5, 2026, one day after CRL reported Q3 2026 earnings that beat consensus estimates.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access